We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Exicure Inc is a clinical-stage biotechnology company that develops nucleic acid therapies targeting ribonucleic acid against validated targets for neurological disorders and hair loss. It operates in a single segment, which is the discovery, research, and development of treatments based on its SNA ... Exicure Inc is a clinical-stage biotechnology company that develops nucleic acid therapies targeting ribonucleic acid against validated targets for neurological disorders and hair loss. It operates in a single segment, which is the discovery, research, and development of treatments based on its SNA (Spherical Nucleic Acid) technology. Show more
Exicure, Inc. (Nasdaq: XCUR, the "Company") has historically been an early-stage biotechnology company focused on developing nucleic acid therapies targeting ribonucleic acid against validated...
American International Group (NYSE:AIG) – AIG has appointed Keith Walsh as Executive Vice President and Chief Financial Officer, effective October 21. Walsh brings over 20 years of...
Exicure, Inc. (“Exicure” or the “Company”) (Nasdaq: XCUR), announced today that on September 17, 2024, the Company received notice that the Nasdaq Hearings Panel (“Panel”) granted an extension to...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0.22 | 8.42911877395 | 2.61 | 3.5402 | 2.57 | 102412 | 2.93503174 | CS |
4 | -0.07 | -2.41379310345 | 2.9 | 3.5402 | 2.33 | 50652 | 2.88486644 | CS |
12 | 0.875 | 44.7570332481 | 1.955 | 6 | 1.44 | 1139799 | 2.71806327 | CS |
26 | 0.19 | 7.19696969697 | 2.64 | 6 | 1.44 | 1644967 | 2.82185578 | CS |
52 | -0.02 | -0.701754385965 | 2.85 | 6 | 1.44 | 1088973 | 2.86303584 | CS |
156 | -2.62 | -48.0733944954 | 5.45 | 16.2 | 0.423 | 2660042 | 1.37205968 | CS |
260 | -11.17 | -79.7857142857 | 14 | 19.2 | 0.423 | 1845844 | 2.52396902 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions